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INTRODUCTION 
Within a short span of time, Ischaemic Heart Disease (IHD) will be the number 
one killer replacing infections, silently, slowly sometimes suddenly occluding the 
coronaries of millions of Indians. WHO study group on IHD and atherosclerosis 
described ischaemic heart disease as “cardiac disability, arising from reduction or arrest 
of blood supply to the myocardium in association with disease process in coronary 
arterial system.” During the past 30 years, a large decline in mortality due to coronary 
artery disease has been experienced in the West and there is a substantial increase in the 
developing countries. IHD accounted for 15.3 million deaths in 1996 which included 
45.6% of all deaths in developed countries and 24.5% of all deaths in the developing 
countries. Estimated and projected rates of death (per l,00,000) due to this dreaded 
disease by World Bank Health Sectoral Priorities Review are 295 and 239 for males and 
females respectively in the year 2015. 
Coronary artery disease has a multifactorial etiology with many of the risk factors 
being influenced by life style. Rapid change in dietary habits coupled with decreased 
physical activity in India as a consequence of urbanisation may partly explain the 
escalation of coronary artery disease. India is at going through a phase of rapid 
urbanization which has led to economic improvement, the consequence of which has 
resulted in fast food intake and tobacco consumption and decreased physical activity. 
 
Atherosclerosis, which is the main cause of coronary artery disease is the 
accumulation of lipids, blood products, fibrous tissue, etc in the arterial wall. Although 
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the precise cause of atherosclerosis is unclear an emerging paradigm suggests that 
atherosclerosis involves multiple pathways in which lipoprotein entry and retention, 
injury to vessel wall from diverse stimuli and an associated long term inflammatory and 
immune response. 
The standard 12 lead ECG has long been a reliable clinical tool for diagnosis of 
myocardial infarction. Minutes may be crucial in making the decision for urgent 
interventions in order to salvage the severely ischaemic myocardium. Besides history and 
physical findings the ECG may be the only clinical tool available readily in deciding to 
initiate life saving thrombolysis. 
Identification of post infarction patients at risk for cardiac death and sudden 
cardiac death may lead to optimization of medical therapy and implantation of 
cardioverter-defibrillators. In the current era of technological development in cardiology 
there are a number of methods that could be utilised for the risk stratification purposes. 
Historically left ventricular ejection fraction was the first widely accepted risk stratifier in 
post infarction patients. Subsequently interest in Holter recorded ventricular arrhythmias, 
late potentials on signal averaged ECG, heart rate variability, substantiated prognostic 
value of these parameters in patients with prior myocardial infarction. New approaches, 
inc1uding heart rate turbulence, T wave alternans, QT variability and baroreflex 
sensitivity are being successfully tried for risk stratification purposes. Simultaneous1y 
invasive electrophysiology testing with induction of ventricular tachycardia or fibrillation 
has been utilized for risk stratification purposes. The concrete evidence for dire 
usefulness will known after extensive trials. All the above methods are worth exploring 
and there are some advantages and limitations of these methods. There is a limited 
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general access to the technology and methodology needed to implement some of these 
more sophisticated technique and also there are no standardizations of several of these 
methods. A standard 12 lead ECG is widely, easily available and serves as a powerful 
tool when considering risk stratification in post infarction patients. So a standard 12 lead 
ECG is a cost effective excellent tool for estimating the severity of myocardial infarction 
especially in developing countries like India. 
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AIMS AND OBJECTIVES 
1.  To study the “QRS duration” on short term prognosis of acute myocardial 
infarction. 
2.  To study the QRS duration in relation to 10-day hospital mortality. 
3.  To study R/Q ratio in lead II for the assessment of the severity of acute inferior 
wall myocardial infarction. 
4.  To study the R/Q ratio in lead II in relation to thrombolytic therapy in acute 
inferior wall myocardial infarction. 
5.  To study the comparison of R/Q ratio with QRS duration to assess the severity of 
acute inferior wall myocardial infarction. 
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REVIEW OF LITERATURE 
At the threshold of the new millennium coronary artery disease is looming large 
as the new epidemic, afflicting Indians with severe and diffuse form of lesions. The 
prevalence of coronary artery disease increased in India during the latter half of the last 
century particularly among the urban population. (1) 
The risk of coronary artery disease in Indians is 3 times higher than white 
Americans, 6 times higher than Chinese and 20 times higher than Japanese. Indians are 
prone as a community to coronary artery disease at a much younger age. (2) 
In a metaanalysis Gupta and Gupta (1996) (3) estimated the prevalence of 
coronary artery disease among Indians to be 9.6% in the urban and 3.7% in the rural 
population. South Indians have a higher prevalence and 14 % in urban areas. 
On screening persons over the age of 30 years by a 12 lead ECG in Chandigarh 
the prevalence was found to be 65.4 and 47.8 per 1000 males and females respectively. In 
a village of Haryana the prevalence was 22.8 and 17.3 per 1000 males and females 
respectively .(4) 
Although the death rate from acute myocardial infarction has declined by about 
30% over the last decade, it is seen as a fatal event at the onset itself is seen in 
approximately one third of patients. About 50% of the deaths associated with acute 
myocardial infarction occur within 1 hour of the event and are attributed to serious 
arrhythmia most often ventricular fibrillation. (5) 
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Almost all myocardial infarction results from coronary atherosclerosis, generally 
with superimposed coronary thrombosis, slowly forming high grade stenosis in epicardial 
coronaries may progress to complete occlusion, but yet does not usually precipitate acute 
myocardial infarction, probably because of the development of a rich collateral network 
over time. (6) 
PATHOPHYSIOLOGY 
On interruption of antegrade flow in an epicardial coronary artery, the zone of 
myocardium supplied by that vessel immediately losses its ability to shorten and perform 
contractile work (7), Four abnormal contraction patterns develop in sequences  
a.  Dyssynchrony - Dissociation in the time course of contraction of adjacent 
segments. 
b.  Hypokinesis - Reduction in the extent of shortening. 
c.  Akinesis - Cessation of shortening. 
d.  Dyskinesis - Paradoxical expansion and systolic bulging. 
Accompanying the dysfunction of the bulging segment, initially there is 
hyperkinesis of the remaining normal myocardium. This increased motion subsides 
within 2 weeks of infarction, during which time, some recovery can be seen in the infarct 
region as well. Patients with acute myocardial infarction also show reduced myocardial 
function in the non-infarcted lesion i.e. ischemia at distance.(8)  
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Clinical features: Chest pain and chest discomfort, are the predominant presenting 
features of myocardial infarction. Nausea, vomiting and epigastric discomfort, 
stimulating an abdominal pathology, occurs more commonly in patients with IWMI than 
AWMI. The stimulation of vagus nerve or Bezold-Jarisch reflex is presumed to be the 
mechanism involved. In elderly patients and diabetics, acute myocardial infarction can 
manifest clinically without chest pain, but with symptoms of acute LVF and chest 
tightness, or by marked weakness, or syncope. (9) Patients usually appear anxious and in 
considerable distress. Sinus bradycardia is particularly frequent in, patients with inferior 
and posterior wall infarction. (10) Hypotension, engorged neck veins, clear lung fields 
and heart blocks are characteristic features of right ventricular myocardial infarction, 
which occurs in about one-third cases of IWMI. (11) 
On cardiac auscultation a fourth heart sound is almost always present in, patients 
with acute myocardial infarction in sinus rhythm and this is usually best heard between 
the left sternal border and the apex. In cases of RVMI associated with papillary muscle 
dysfunction of the tricuspid valve, murmur of TR may be present. (7) In, patients with 
IWMI, posterior involvement are associated with development of significant MR (12). 
The incidence of cardiogenic shock and severe LVF occurs less frequently in 
IWMI, unless otherwise, it is complicated by mechanical defects such as ventricular 
septal rupture, papillary muscle dysfunction or predominant RV infarction (7). 
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Cardiac Enzymes 
Estimation of the rise and fall in serum cardiac markers is one of the WHO 
criteria for diagnosis of AMI, other being history of ischemia and electrocardiographic 
changes. (13). 
In myocardial infarction, as myocytes become necrotic, the integrity of the 
sarcolemmal membrane is compromised and intracellular macromolecules (serum cardiac 
markers) begin to diffuse into the cardiac interstitium and ultimately into the 
microvasculature and lymphatics in the region of infarcts. (14) The rate of appearance of 
these macromolecules depends on several factors including intracellular location, 
molecular weight, local blood supply and lymphatic flow, and the rate of elimination 
from the blood. (15). 
Among the various serum cardiac markers; cardiac specific troponin (Tn-c, Tn-I), 
Creatinine kinase (CPK-MB), Myoglobin and LDH are the commonly measured, with 
troponin now considered as the preferred biomarker for diagnosis of acute myocardial 
infarction (16). Serum level of cardiac enzymes appears to be the most practical means of 
estimating infarct size (17). In addition, cardiac troponin measurements have been shown 
to have prognostic value for identifying patients with an acute coronary syndrome at risk 
for adverse clinical outcomes and who also exhibit enhanced responsiveness to new 
therapies such as glycoprotein IIb/IIIa inhibitors and low molecular weight heparin (18). 
Studies have shown that patients with IWMI who have anterior ST segment 
depression and RVMI, have got higher cardiac enzyme values, indicating a larger mass of 
myocardial involvement. (19) 
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ELECTROCARDIOGRAPHY 
The value of ECG in diagnosing and localizing the size of infarction is 
unequivocal. (20) The 12 lead ECG remains the centre of decision pathway for 
management of patients with acute coronary syndrome and to distinguish between the 
presentations of those with and without ST segment elevation (21). Katz et al (1946)(22) 
set the criteria for electrocardiographic diagnosis of myocardial infarction. Myocardial 
infarction was classified into transmural and non-transmural. Transmural were those 
demonstrating significant Q wave plus typical ST-T wave alteration and T wave 
inversion. In non-transmural infarcts, the established ST segment alteration and T wave 
inversion persisted beyond 7 days, but with no significant Q waves. 
The inferior wall of the left ventricle is directed to the standard leads II, III and 
aVF (23). The hyperacute phase is manifested by increased ventricular activation time, 
increased amplitude of R wave, straightening and subsequent slope elevation of the ST 
segment, tall and widened T waves. 
In the fully evolved phase, standard lead III commonly reflects a QS complex, 
while standard lead II and aVF however usually reflect a QR complex. The disappearance 
of the small normal initial Q in lateral leads is a corroborative sign of IWMI. Reciprocal 
ST segment depression usually occurs in the right precordial leads. (24) 
Q waves are frequently seen in lead III in normal patients, so to enhance the 
specificity of Q wave in lead III, guidelines have been laid down. According to Harpaz D 
et al (1999) (25), Q wave should he greater than 0.03 seconds. To increase the specificity 
of Q wave in lead III, Minnesota code modification (26) advised:  
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• Q in Lead II greater than 0.0 3second. 
• Lead III Q greater than 0.03sec and Q greater than or equal to 1mm in 
lead aVF. 
• Lead aVF, Q greater than 0.03 see. 
Along with IWMI, changes in the lateral leads (l, aVL, V5, V6) with an 
isoelectric or elevated ST segment in lead I identifies obstruction of the circumflex 
coronary arteries with a sensitivity specificity and predictive value of 83%,  96% and 
93% respectively. Changes in lateral leads are rare in IWMI resulting from obstruction of 
the RCA. (27) 
ECHOCARDIOGRAPHY 
Evaluation of LV Function: 
The parameters of systolic and diastolic function can be obtained by M mode or 
2D echocardiography, either by measuring left ventricular dimension in systole and 
diastole or with LV volumes calculated by area length method in apical2D view. 
Systolic Function: The three commonly used indices of systolic LV function are  
LV Ejection Fraction = (EDV - E3V / EDV) X 100 
Normal- in male 59±6 and in female 58±7 
Fractional Shortening (FS) = (LVIDd - LVIDs / LVIDd) X 100 
Normal - > 24 % 
E-Point Septal Separation (EPSS) 
Normal - Upto 8 mm. 
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Diastolic Function: The function is assessed by Doppler echocardiography by 
calculating several indices but those in common use include peak ‘E’ velocity, peak ‘A’ 
velocity,  E/A ratio and isovolumeic relaxation time. (28) 
Segmental Wall Motion Analysis 
The American Society of Echocardiography Committee (ASE) on Standards 
recommended a semi-quantitative method that derives wall motion score based on a 
visual impression of regional wall motion. The left ventricular mass can be divided into 3 
equal levels from the apex to base length, resulting in its partition into basal, middle and 
apical levels. They proposed a 16-segment model for visual semi-quantitative wall 
motion analysis. (29) 
The proposed segments are 
 Base Mid Apical 
 Basal Anterior Anterior Anterior 
Basal Anteroseptal Anteroseptal Inferior 
Basal lnferioseptal Inferioseptal  Lateral 
Basal Inferior Inferior Septal 
Basal Posterior Posterior  
Basal Lateral Lateral  
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The five basic wall region visualized are 
Anterior Wall: Which was considered to extend over the anterior surface of 
ventricles from the anterior interventricular sulcus, around the free ventricular wall to the 
origin of the anterior papillary muscle. 
Posterolateral wall: was considered to extend posteriorly between the papillary 
muscles.  
Inferior wall: Extended from the posterior papillary muscle to the junction with 
the septum at the posterior interventricular sulcus. 
Septal Region: Included the septum. 
Apical Region: Included the very tip of ventricular cavity and apex. 
One can relate the various segments to coronary artery distribution 
Anterior and anteroseptal segments in both basal and middle third and the apical 
segments - left anterior descending artery distribution. 
Basal, lateral and middle lateral - left circumflex artery distribution. 
Posterior and inferoseptal in both the basal and middle third - right coronary 
artery distribution. 
Scoring Scale: Henry et al (1979) (30) stated that at least 50% of the 
endocardium must be visualized in anyone segment throughout the cardiac cycle for 
reliable prediction of presence or absence of LV and RV asynergy. A significant concern 
was the ability to grade 2D echo images and distinguish normal from hypokinetic wall 
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motion. For this, strict attention was paid not only to the endocardial inward motion but 
also to the wall thickening. Liberman et al (1981) (31), showed that systolic thickening 
provided better separation of normal from infarcted myocardium than endocardial motion 
alone. 
The ASE committee has also proposed the following scoring scale for 
standardization of wall segment motion 
Score Wall Motion                     Definition 
1. Normal Normal endocardial inward motion and wall thickening in 
systole 
2. Hypokinesis Reduced endocardial motion and wall thickenil1g in systole 
3. Akinesis Absence of endocardial inward motion or wall thickening in 
systole 
4. Dyskinesis Outward motion or bulging of the segment in systole, usually 
associated with thin, scarred myocardium. 
Wall Motion Score Index: It can be derived from the sum of all scores divided by 
the number of segments visualized. (32). 
Assessment of Overall Performance of the Ischemic Left Ventricle: 
Left ventricular ejection fraction (LVEF) is one of the most commonly used 
indices of systolic LV function. 2DE is a useful noninvasive method for estimation of LV 
volume and LVEF. 
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Following myocardial infarction, there is a decrease in LVEF and this is directly 
related to the amount of damaged myocardium and the extent of potentially ischemic 
muscle. Morbidity and mortality rates correlated well with initial ejection fraction. 
Patients with ejection fraction <30-35% had greater risk of pump failure and death. 
Patients with AWMI had a lesser LVEF (38±14) as compared to those with 
inferoposterior wall myocardial infarction (55±10) because a greater region of 
myocardium was involved in AWMI. (33). 
In patients with IWMI, both LVEF and RVEF are depressed, whereas in patients 
with AWMI, RVEF generally remains normal. But while RV performance rapidly 
improves with prompt return to normal level, as early as 2 days after infarction, there is 
less improvement in the LVEF. (34) 
Carr et al (1979) (35) in their study found that cross-sectional echocardiography 
and radionudeotide angiography were of equal value in the estimation of LVEF. 
Although radionuc1eotide ventriculography generally provides a more exact 
measurement of ejection fraction, echocardiography appears to be capable of directly or 
subjectively evaluating ventricular function well enough to identify patients with risk of 
death from myocardial infarction. (33). 
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COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION 
Mechanical Complications: 
1. Left Ventricular Failure: Even in thrombolytic era, left ventricular dysfunction 
remains the single most important predictor of mortality after acute myocardial 
infarction. In patients with acute myocardial infarction, heart failure is characterized 
either by systolic dysfunction alone or by both systolic and diastolic dysfunction. Left 
ventricular diastolic dysfunction leads to pulmonary venous hypertension and pulmonary 
congestion whereas systolic dysfunction is principally responsible for a depression of 
cardiac Output and of the ejection fraction. Clinical manifestations of left ventricular 
failure become more common as the extent of the injury to the left ventricle increases; 
mortality increases in association with the severity of the hemodynamic deficit. 
 
Hemodynamic Classification of Patients with Acute Myocardial Infarction: (Killip 
Classification) 
Class     Based on Clinical Examination   Based on Invasive Monitoring  
I No evidence of pulmonary congestion   Normal     
 
II  Mild evidence of pulmonary congestion  Pulmonary congestion PCWP > 18 
        CI<2.2 
III Pulmonary oedema    Peripheral Hypoperfusion   
       PCWP>18   CI>2.2                  
IV  Cardiogenic Shock    Pulmonary congestion and peripheral    
       hypoperfusion PCWP>18,CI>2.2 
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2. Cardiogenic Shock: The severest clinical expression of left ventricular failure is 
associated with extensive damage to the LV myocardium (about 40%) in more than 80% 
of acute myocardial infarction patients in whom it occurs. The remainder have a 
mechanical defects such as ventricular septal defect or papillary muscle rupture or 
predominant right ventricular infarction. In the part cardiogenic shock has been reported 
to occur in upto 20% of parents with acute myocardial infarction, but estimates from 
recent large randomised trials of thrombolytic therapy and observational databases report 
an incidence rate in the range 7% About 10% of patients with cardiogenic shock present 
with this condition at the time of admission, whereas 90% develop it during 
hospitalisation (36). Patients with cardiogenic shock due to acute myocardial infarction 
are more likely to be older to have a history of a prior myocardial infarction or congestive 
heart failure and to have sustained an anterior infarction at the time of development of 
shock. 
 
Arrhythmias: 
Electrical instability: VPC’s, VT, VF, AIVR, NPAVJT 
Pump failure/ excessive sympathetic stimulation: Sinus tachycardia AF / Afl, 
PSVT 
Bradyarrhythmias and conduction disturbances 
Sinus bradycardia, junctional escape rhythm AV block and intraventricular block 
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Progression of Acute Myocardial Infarction: Most of the thrombolytic trial shows that 
mortality in IWMI is about half that of AWMI.  
Name of 
Studies 
AWMI IWMI 
No. of  
Deaths 
No. of 
Patients % 
No. of  
Deaths 
No. of 
Patients % 
GISSI-I 403 2193 18.4 145 2004 7.2 
ISIS 329 1827 18.0 185 2112 8.8 
AIMS 51 292 17.5 26 225 7.8 
ASSRT 134 796 16.8 77 773 10.0
LATE 58 410 14.2 30 351 8.6 
 Average - 16.98% Average – 8.48% 
     
Certain high risk subgroups can be identified in IWMI by single ECG criteria. 
These are right precordial ST segment elevation, left precordial ST segment depression 
and high degree AV block. 2D echo can also diagnose high risk subgroups like those 
having RV and posterior wall assynergy, patients having poor ejection fraction, high wall 
motion index score, VSD, papillary muscle ruptures etc. These high risk subgroups have 
similar mortality rates as of AWMI, while the low risk subgroups have got mortality rates 
around 2-4 % (37). 
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The results of thrombolytic trials in myocardial infarction show that thrombolysis 
in IWMI is statistically not as significant as in anterior wall myocardial infarction and it 
has got only a meager impact in the mortality reduction. 
Studies Thrombolytic          Deaths/ Patients 
Control Deaths/ 
Patients 
Streptokinase 
GISSI-I (0-12 h) 137/2009 (6.8%) 145/2004 (7.2%) 
ISIS-2 (0-24h) 150/2076 (7.2%) 185/2112 (8.8%) 
SK/ASA ISIS-2 (0-24h) 69/1016 (6.8%) 107/1047 (10.2%) 
Altepase 
ASSET (0-5h) 46/734 (6.3%) 77/773 (10.0%) 
LATE (6-12h) 34/381 (8.9%) 30/351 (8.6%) 
Prognostic Significance of ECG in Acute Myocardial Infarction 
Standard 12 lead ECG serves as an extremely useful tool in risk stratification after 
myocardial infarction. Careful analysis of ECG provides comprehensive information 
about pathology of the heart, which could lead to cardiac events including reinfarction, 
progression of heart failure and death. Identification of post infarction patients at risk or 
cardiac death and sudden cardiac death may lead to optimization of medical therapy and 
implantation of cardioverter defibillators. 
QRS Duration and Myocardial Infarction  
In a study by Pudil et al (2001) (38), acute myocardial infarction with 
intermediate QRS duration (0.09-0.11sec) on admission electrocardiogram was 
independently associated with increased 7 day, 0 day and 1 year all cause mortality. 
 19
More recently it was shown that QRS duration of the admission 
electrocardiogram is independently associated with 30 days and 1 year mortality after 
acute myocardial infarction in the GUSTO-1 trial. In this trial QRS prolongation had a 
more significant outcome in patients with anterior myocardial infarction (39). 
Prolonged QRS duration on surface electrocardiogram was associated with left 
ventricular dysfunction in patients referred to radionucleotide exercise ventriculography. 
It was also reported that QRS (duration > 0.1 seconds indicated decreased left ventricular 
ejection fraction .(40). 
A QRS of < 0.09 seconds on admission electrocardiogram is indicate of a relative 
benign outcome compared with a QRS duration of >0.09 seconds. 
The mechanism by which prolonged QRS duration on admission is associated 
with increased risk of death is not clear. Multiple physiologic parameters associated with 
poor outcome can lead to prolonged QRS duration in patients with acute myocardial 
infarction including increased left ventricular muscle mass, myocardial fibrosis, increased 
area of necrosis, involvement of conduction system in the ischaemic area, poor metabolic 
state that slows conduction, and effects of various medications. 
After adjusting for all significant variables associated with mortality, including 
age, gender, diabetes mellitus, smoking, systemic hypertension, Killip class>2 on 
admission and anterior location of myocardial infarction prolonged QRS duration both in 
the those with QRS duration> 0.11 seconds was found to be independently associated 
with increased 7 day, 30 day and 1 year mortality  (38). 
 20
QRS prolongation was positively associated with older age, female gender, 
anterior myocardial infarction and congestive heart failure on admission. 
In 743 patients of the placebo arm of the cardiac arrhythmia suppression trial 
1991 with stable coronary artery disease and QRS duration >100 ms, the risk ratio was 
1.4 for new or worsening congestive heart failure, 1.5 for arrhythmic death or cardiac 
arrest and 1.4 for all cause mortality (p<.05). In post acute myocardial infarction patients 
QRS prolongation was significantly correlated with arrhythmic events (41). 
In patients with normal coronary arteries, QRS duration decreases with exercise 
probably because of an increase in the sympathetic tone. In contrast, in patients with 
coronary artery disease, QRS duration increases during exercise testing. Michaelids et al, 
1993(42) reported that exercise induced QRS prolongation was proportional to the 
number of coronary arteries with >70% stenosis. Mean QRS prolongation was 4.8±7.5 
ms in patients with I-vessel disease, 7.8±11.8 ms in patients with 2-vessel disease and 
13.3±12.1 ms in patients with 3-vessel disease (p< 0.001). 
Distortion of the terminal portion of the QRS complex in the admission ECG is an 
independent predictor of increased hospital mortality in patients receiving thrombolytic 
therapy >2 hour after the onset of symptoms. During regional myocardial ischemia the 
conduction velocity of the activation wave in the Purkinje fibres is prolonged .(43) 
QRS prolongation on surface electrocardiography has been identified as a marker 
for increased cardiac mortality. A potential mechanism for increased mortality is 
ventricular tachycardia. Patients with prolonged QRS duration were older had lower 
LVEFs and were more likely to have a history of myocardial infarction. Prolonged QRS 
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was a significant predictor of sustained monomorphic VT inducibility (p< 0.0001). On 
Multivariate analysis correcting for age, sex, LVEF, history of myocardial infarction, 
medication and QRS conduction delay proved to be independently associated with 
sustained monomorphic VT inducibility (relative risk 3.290, 95% confidence interval 
2.185 to 4.953 for prolonged vs. normal QRS duration) (44). 
At multivariate analysis, prolonged filtered QRS duration had an independent 
relation to late arrhythmic events after acute myocardial infarction. (45) 
QRS duration remains a very powerful predictor of future cardiac events in post 
infarction patients (46). QRS duration reflects well the magnitude of left ventricular 
dysfunction and therefore not surprisingly is a powerful predictor of mortality in post 
infarction patients.(40). A study by Fadl et al (2003) (47) in a large population of post 
infarction patients indicate that QRS duration 0.12 second is associated with hazard ratio 
of 1.7; p = 0.001. 
Significance of R/Q Ratio in Lead II in Inferior Wall Myocardial Infarction 
Inferior wall of the heart is constituted by the inferior wall of left ventricle and is 
oriented to the positive electrodes of lead II, III, avF. 
Inferior wall myocardial infarction has 3 phases  
1.  Early hyper acute - characterized by elevation of ST segments. 
2.  Ful1y evolved phase - characterized by the presence of pathological Q or QS 
complexes coved and elevated ST segments and inverted sharply pointed and 
symmetrical T waves in lead II, III, avF. 
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3.  Chronic stabilized phase - Characterized by residual Q wave abnormalities in 
leads II, III, avF, particularly in lead II, avF. 
 
Pathological Q waves of inferior wall myocardial infarction are not usually deep 
or as wide as the pathological Q waves which occur with anterior wall myocardial 
infarction because inferior wall myocardial infarction is reflected by extremity leads (48). 
In IWMI a QS complex is usually present in lead III and avF. Standard lead II 
usually reflects Qr or QR complex. In inferior wall myocardial infarction, among the 
inferior leads tallest terminal R wave is seen in lead II. (48) 
We can explain this distribution of terminal R wave by considering the anatomy 
of inferior wall. We can divide the inferior wall into right lateral and left lateral region. 
Lead III is oriented to right lateral region and lead II to left lateral region. 
The brunt of infarction affects the right lateral region of inferior wall with sparing 
of left lateral region so lead III reflects the largest and widest QS complex, lead II 
however is oriented to left lateral region of inferior wall reflects the potentials of healthy 
overlying muscle as a terminal R wave; so loss of R wave in lead occurs mainly in 
extensive inferior wall myocardial infarction
 23
 
 
Two major determinants of clinical outcome in patients with acute myocardial 
infarction are the extent of infarction and the residual left ventricular function  (49). 
In patients with inferior wall myocardial infarction terminal R wave and R/Q ratio 
in lead II reflects the extent of infarction and residual function so by calculating R/Q ratio 
in lead II we can define the severity of inferior wall myocardial infarction. 
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Alexander Arditti et al (1985) (50) studied a simplified QRS scoring system for 
the estimation of the severity of acute inferior myocardial infarction. 
Electrocardiographic assessment of the R/Q ratio in lead II of patients with first acute 
inferior wall myocardial infarction offers important indirect evidence of severity and 
extent of myocardial infarction. An R/Q ratio of more than 2 predicts mild and localized 
left ventricular involvement with good global left ventricular function and good clinical 
course. An R/Q ratio between 1 and 2 predicts a greater degree of local asynergy with 
some lateral extension with reduced global left ventricular function, but still a good 
clinical outcome. R/Q ratio less than one predicts severe inferior wall asynergy with high 
incidence of lateral wall involved, reduced global left ventricular function and 
complicated clinical course during the acute phase. 
Eliezer et al (1988) (51) conducted similar study in which acute inferior wall 
myocardial infarction were divided into three groups according to the R/Q ratio in lead II. 
This was done to correlate these groups with characteristic course to electrocardiographic 
status. Patients with R/Q > 2 (group 1) had a more rapid progression through the 
electrocardiographic stages along with better clinical course than patients with lower R/Q 
ratio. Patients in group In with R/Q < 1 had a slower electrocardiographic stage 
progression which correlates well with a more complicated clinical course. Group II was 
an intermediate group in both the electrocardiographic and clinical course. It is suggested 
that the R/Q ratio in lead II can be used as a marker of the severity of IWMI since it 
correlates well with the course of electrocardiographic stages. This may be an additional, 
simple and inexpensive electrocardiographic tool for following the natural course of 
IWMI. 
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Lewin (1986) (52) conducted a study in which acute inferior wall myocardial 
infarction were divided into three groups. Group I predominant right ventricular 
infarction, group II combined right and left ventricular infarction and in group III 
predominant left ventricular infarction. Patients with predominant RV infarction (Group 
I) had smaller Q wave values and taller mean R wave in the inferior leads than patients in 
the other groups. In predominant RV infarction R/Q ratio> 2.5 and is combined RV and 
LV or extensive LV infarction R/Q ratio is < 2.5. 
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MATERIAL AND METHODS 
The study was carried out on 75 patients admitted in ICCU of Department of 
Medicine, Government Royapettah Hospital, Kilpauk Medical College, Chennai-10. 
SELECTION CRITERIA: 
In this study 75 cases of both sexes of more than 20 years of age with first episode 
of myocardial infarction, typical chest pain of more than 30 minutes, onset of symptoms 
within previous 6 hours, at least 0.2 mv ST segment elevation in two or more contiguous 
precordial leads or at least 0.1mv ST segment elevation in two or more leads were 
included. 
The screening criteria for the identification of the presence of myocardial 
infarction were: 
• Inferior criterion: Q>30 msec in lead aVF 
• Anterior criteria: A Q or R< 0.1 mv and < 10 m sec in V2. 
EXCLUSION CRITERIA 
Patients with ECGs showing evidence of LBBB, RBBB, LAHB, LVH, old 
myocardial infarction, preexicitation syndrome were excluded from the present study. 
All cases were subjected to following examination. 
Case number, registration number, father/husband name, age, sex, socio-
economic status and rural urban background etc. 
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Presenting complaints with duration were noted in detail such as chest pain, its 
site, duration and radiation, accompanying features like sweating, nausea, vomiting, 
syncope, breathlessness, palpitation, oedema, abdominal distension, right hypochondrial 
pain and other atypical symptoms. 
Detailed symptomatology of clinical presentation was sought with special 
reference to onset, duration, intensity, relationship to circadian and seasonal rhythm of 
symptoms. 
Past History 
It was taken to exclude the presence of a previous myocardial infarction and to 
find out the risk factors including hypertension, diabetes mellitus and other evidence of 
atherosclerotic disease like CVA. 
Family History 
Family history of diabetes mellitus, coronary artery disease, hypertension, 
dyslipidemia, age of death were enquired for. 
Personal History 
It was taken with special reference to addictions like tobacco chewing, smoking, 
alcohol consumption, dietary habits etc. 
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General Examination: 
It was done meticulously in all cases, special care was taken to record pulse rate, 
rhythm, volume, character and condition of arterial wall. Blood pressure was taken to 
supine position. Presence of pallor, cyanosis, pedal oedema and raised JVP was noted. 
Systemic Examination 
• Detailed Cardiovascular system examination was done by observing, 
palpating apex impulse, thrills, precordial pulsations were looked for, heart 
sounds S1, S2, S3 and S4, murmurs were auscultated. (site, duration, timing, 
character and radiation). 
• Respiratory system was examined by auscultating for breath sounds and to 
look for evidence of pulmonary oedema. 
• Abdominal examination was done for the presence of any organomegaly and 
ascites. 
• Central nervous system was examined for presence of any neurological 
deficit. 
Investigations 
The following investigations were done in all cases. 
• Haemogram - Hb, TLC, DLC, ESR. 
• Urine - Albumin, Sugar and Microscopy 
• Blood - Urea, sugar, Serum cholesterol and serum creatinine. 
 29
 
Electrocardiogram: 
12 lead ECG was taken in all cases taking special precautions while placing the 
chest leads. Repeat ECGs were taken every day on first three consecutive days of 
admission followed by every alternate day until 10th day. 
Rigorous Definition of Wave Forms 
When the initial aspect of the QRS complex is negative, a Q wave is present. 
Prior to returning to the baseline, this negative deflection may be smooth or notched. A 
smooth q wave is present when the initial negative deflection contains no reversal in the 
direction of 0.05 mv or more. 
The duration and amplitude of such Q wave are measured as the width and depth 
respectively of the initial negative deflection. 
A notched Q wave is present if there is a reversal in direction of 0.05 mv or more 
within the initial negative deflection. In this instance, the duration of the Q wave should 
be measured along the PR baseline only to the point directly above the peak of the notch 
and remainder of the negative deflection should not be considered. The amplitude of the 
Q should be measured to the nadir of the negative deflection preceding the notch. 
An R wave is defined on the initial positive deflection. A notched R wave is 
present if there is a reversal in direction of 0.05 mv or more within the initial 40 ms of the 
QRS complex. 
 
 30
 
Accurate Wave from Measurement: 
Careful manual measurement of both amplitudes and duration should be made 
with calipers using center of the trace of the inscribed waveform. 
 
Rand Q wave amplitude and resultant R/Q ratio were calculated in lead-II using 
the mean value of 3 consecutive QRS complexes and the TP segment as baseline on 3rd 
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and 7th day of hospitalisation. By using 3rd day R/Q ratio on lead-II short term prognosis 
of inferior wall myocardial infarction was evaluated. By comparing R/Q ratio on 7th and 
3rd day the relationship of thrombolysis and R/Q ratio was evaluated. 
For the study, patients of inferior wall myocardial infarction were divided into 
groups according to R/Q ratio in lead II on 3rd day. 
Group I  Includes patients of IWMI with R/Q ratio> 2  
Group II  Includes patients of IWMI with R/Q ratio 1- 2  
Group III Includes patients of IWMI with R/Q ratio < 1 
For the study of QRS duration, widest QRS duration in standard lead was 
manually measured on 3rd day of hospitalisation. 
Only leads without extreme ST segment deviation were considered. According to 
the QRS duration, patients of myocardial infarction including both inferior and anterior 
wall myocardial infarctions were divided into 3 groups. 
Group A With QRS duration < 0.09 See. 
Group B With QRS duration 0.09 - 0.11 sec (intermediate QRS 
prolongation) 
Group C With QRS duration > 0.11 sec (Significant QRS prolongation) 
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ECHOCARDIOGRAPHY 
The 2 dimensional echocardiography study was performed on the 7th day post 
myocardial infarction, with the patient in the left lateral decubitus position with Toshiba 
Model SSH -140 echocardiography machine. A 3.75 MHz phased array sector transducer 
was used. The left ventricle was studied as recommended by American Society of 
Echocardiography in the long and short view. 
The committee proposed the following scoring scale for standardization of wall 
segment motion. 
A normally contracting segment or a hypercontracting segment is assigned a score 
of 1, Hypokinesia 2, Akinesia 3, Dyskinesia 4 and aneurysmal segment 5. 
Dyssynergy of a LV segment was defined as Hypokinesis, Akinesis or Dyskinesis 
involving> 50% of that segment. 
The ejection fraction was calculated by the standard formula as recommended by 
American Society of Echocardiography 1989(ASE).  
Left Ventricular Ejection Fraction: 
     EDV -ESV 
(LVEF) =--------------------------- X 100 
   EDV 
EDV = End Diastolic volume  
ESV= End Systolic Volume  
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Normal> 60% 
The QRS duration and R/Q ratio were evaluated with ejection fraction and 
regional wall motion abnormalities. 
 
Statistical Analysis 
In present study comparison among the three groups using tables and graphic 
presentations were performed. The analysis between groups was performed using student 
‘t’ test or the Chi Square test when indicated. All data were expressed as mean standard 
deviation. A value of < 0.05 was considered statistically significant. 
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OBSERVATION 
The present series “Study of QRS Duration and R/Q ratio in the assessment of 
Severity of Acute Myocardial Infarction” was carried out on 75 patients admitted in 
ICCU of Department of Medicine, Government Royapettah Hospital, Kilpauk Medical 
College, Chennai-10. 
 
Table No.1 
Distribution of Type of Myocardial Infarction 
 
S. No. Type of Myocardial Infarction No. of Cases Percentage 
 1. AWMI 28 37.33 
 2. IWMI 44 58.67 
 3. AWMI+ IWMI 3 4.0 
  Total 75 100.0 
 
58.67% of the patients were having inferior wall myocardial infarction, 37.33% were 
having anterior wall myocardial infarction while 4.0% patients had both anterior and 
inferior wall myocardial infarction. 
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 Table No. 2 
Thrombolytic Therapy in Acute Myocardial Infarction 
S. No Type of M.I. 
 Total Thrombolyzed Non Thrombolyzed 
No. % No. % No. % 
1. AWMI 28 37.33 14 50.0 14 50.0 
2. IWMI 44 58.67 24 54.54 20 45.46 
3. AWMI +IWMI 3 4.00 2 66.67 1 33.33 
 Total 75 100.0 40 53.33 35 46.67 
X2 = 6.06,   p <0.05   Significant 
Out of total cases 53.3% patients were thrombolyzed. 
 
Table No. 3  
Distribution of Ejection Fraction 
 
Type of Myocardial 
Infarction 
< 40% 41-50 % > 50% 
No. % No. % No. % 
AWMI (n-26) 9 34.61 13 50.0 4 15.38 
IWMI (n-41) 7 '17.07 21 51.21 13 31.70 
AWMI +IWMI (n-3) 1 33.33 2 66.67 - - 
Total (n-70) 17 24.28 36 51.42 17 24.28 
 
X2 = 41.86,     p <0.001   Highly Significant 
Five patients expired before Echocardiogrnphy 
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Most of the patients with of anterior wall myocardial infarction had left 
ventricular ejection fraction in the range of 41-50%. Nine patients (34.61%) with anterior 
wall myocardial infarction had left ventricular ejection fraction < 40%, against 17.07% 
patients of inferior wall myocardial infarction. 
 
Table No. 4 
Distribution of Myocardial Infarction in Relation to QRS Duration 
 
ORS Duration 
(In Seconds) 
IWMI AWMI Total 
No. % No. %  
 Group A (<0.09) 32 65.30 17 34.69 49 
Group B (0.09- 0.11) 9 50.0 9 50.0 18 
Group C (>0.11) 6 75.0 2 25.0 8 
Total 47 62.67 28 37.33 75 
X2 = 13.70,   p <0.05   Significant 
65% of the patients with combined inferior wall myocardial infarction and 
anterior wall myocardial infarction were distributed in group A (<0.09) 40% patients with 
anterior wall myocardial infarction alone had QRS duration >0.09 seconds as compared 
to 30% patients of inferior wall myocardial infarction. 
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Table No. 5 
QRS Duration and Cardiac Arrhythmias in Myocardial Infarction 
 
 Arrhythmia 
Group A          
(< 0.09) (n-49) 
   Group B            
(0.09 – 0.11 ) (n-18) 
Group C         
(> 0.11) (n-8)       Total 
No. % No. % No. % No. % 
S.V.E. 3 50.0 1 16.67 2 33.3 6 16.21
V.E. 12 66.67 4 22.22 2 11.11 1R 48.04
S.V.T. - - 2 10O.n - - 2 5.4 
V.T. 3 33.33 4 44.44 2 22.22 9 25.0 
C.H.B. - - 2 100.0 - - 2 5.4 
 
Ventricular ectopics were the most common arrhythmia observed. Maximum 
incidence of ventricular tachycardia was in group B (44.44%). 
 
Table No. 6 
QRS Duration and Regional Wall Motion Abnormality 
 
 Group A Group B Group C   
 RWMA 
(0.09) (0.09 - 0.11 ) (> 0.11)  Total (n-69) 
(n-49) (n-18) (11-8)    
  No. % No. % No. % No. % 
 Hypokinesia 22 84.61 2 7.69 2 7.69 26 37.14 
 Akinesia 24 57.14 14 33.3 4 9.52 42 60.0 
 Normal 2 100.0 - - - - 2 2.86 
 Total 48 68.57 16 22.85 6 8.5 70* 100.0 
 
*5 Patients expired before Echocardiography
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             Akinesia was reported from 24 patients (50%) of group A, 14 patients 
(87.5%) of group B and 4 patients (66.67%) of group C. Hypokinesia was reported 
from 22 patients (46%) of group A, 2 patients (12.5%) of group B and 2 patients 
(33.33%) of group C. Two patients in Group A were having normal regional wall 
motion. 
 
Table No. 7 
QRS Duration and Ejection Fraction 
 
Ejection Group A Group B Group C Total 
  « 0.09) (0.09 - 0.11) (> 0.11)  (n-70) 
 Fraction (n-49) (n-18)          (n-8)  
 (%)         
  No. % No. %    No. % No. % 
 30-40 % 6 35.29 9 52.94 2 11.76 17 24.28 
 40-50 % 25 62.85 7 20.0 3 8.57 35 50.0 
 50-60 % 16 94.1 - - 1 5.9 17 24.28 
 > 60% 1 100.0 - - - - 1 1.42 
 Total 48 68.11 16 23.18 6 8.69 70* 100.0 
*5 Patients expired before Echocardiography. 
 
In Group A, patients with ejection fraction >50 was 35.45%. In Group C 
patients with ejection fraction >50 was 16.7% and in Group B patients had ejection 
fraction >50. 
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Table No. 8 
 Killip Class and Distribution of Cases in Myocardial Infarction in Relation to QRS 
Duration 
 
Killip Class A (n-49) B (n-18) C (n-8)    
 No. % No. % No. % No. % 
I 35 71.4 5 27.78 1 12.5 41 54.67 
II 12 24.48 10 55.55 2 25.0 24 32.0 
    
5.5 
 
50.0 
  
III 1 2.0 1 4 6 8.0 
IV 1 2.0 2 11.11 1 12.5 4 5.3 
Total 49 65.33 18 24.0 8 10.67 75 100.0
Chi square=39.21  p< 0.001 Highly Significant (Gr A vs B) 
Chi square=104.88  p<0.001 Highly Significant (Gr A vs C) 
Chi square=53.15  p<0.001 Highly Significant (Gr B vs C) 
In group A 71.4 % of patients belonged to Killip class I as compared to 12.5% in 
group C. Patients with Killip class > II were 62.5% in group C, 16.6% in group B and 4% 
in group A. 
Table No. 9 
Killip Class with Mean QRS Duration and Ejection Fraction in AWMI 
Killip Class Mean QRS Duration Mean Ejection Fraction 
I 0.08±0.01 47.60±9.82 
II 0.09±0.01 42.20±4.78 
III 0.09 43 
N 0.10 Expired before Echo  
r = 0.9- Significant 
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Mean QRS duration of class I patient was 0.08±0.01 as compared to 0.10 in 
Killip class IV patients. As QRS duration increases Killips Class also increases. 
 
Table No. 10 
10 Day Mortality in Different Groups in Relation to QRS Duration 
 
 Survivors Expired Total 
 QRS Duration      
  No. % No. %  
 Group A (< 0.09) 48 98.0 I 2.0 49 
 Group B (0.09 - 0.11 ) 15 83.35 3 16.67 18 
 Group C(> 0.11) 6 75.0 2 25.0 8 
 Total 69 92.0 6 8.0 75 
       
Chi square= 21.80 p< 0.001  Highly Significant 
 
In the present study out of the 75 patients 6 (8.0%) expired; one from Group 
A (2.0%)/ 3 from group B (16.67%) and 2 (25.0%) from group C. In the mortality 
group, except one patient of AWMI, five of them expired before Echocardiography 
could be done and one after Echocardiography was done. 
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Table No. 11 
Distribution of IWMI According to R/Q Ratio in Lead II 
 
S.No. R/Q Ratio in Lead II No. of Cases Percentage 
 1. Group I (> 2 ) 22 46.80 
 2. Group II (1-2 ) 21 44.68 
 3. Group III (< 1 ) 4 8.51 
  Total 47 100.0 
 
Maximum number of patients were in group I (46.80%) followed by group II 
(44.68%). 
 
Table No. 12 
R/Q Ratio and Complications at the Time of Admission 
 
S. N. Complications  R/Q Ratio  
  Group I (> 2) Group II (1-2) Group III (<1) 
  (n-22) (n-21) (n-4) 
1. Hypotension - 1 (4.76%) 1 (25.0%) 
2. Raised JVP 3 (13.63%) 4 (19.0%) 2 (50.0%) 
3. Arrhythmia 7 (31.81 %) 9 (42.8%) 2 (50.0%) 
Chi square= 22.91 p<0.001 Highly Significant. 
 
All patients of group III had different types of complications of myocardial 
infarction, 50% of them developed arrhythmia, 50% had raised JVP and 25% had 
hypotension as compared to group I where 31.8% patients had arrhythmia, 13.63% had 
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raised JVP and none of them had hypotension 
 
Table No. 13 
R/Q Ratio and Arrhythmia 
 
 Group I Group II Group III Total (n-17) 
Arrhythmia (R/Q > 2) (R/Q 1-2) (R/Q < 1)   
 No. % No. % No.      % No. % 
S.V.E. 1 20.0 3 60.0 1 20.0 5 29.41 
V.E. 4 57.14 3 42.85 - - 7 41.17 
S.V.T. - - 1 100.0 - - I 5.88 
V.T. 1 33.3 1 33.3 1 33.3 3 17.64 
C.H.B. - - 1 100.0 - - 1 5.88 
 
Most common arrhythmia reported was ventricular ectopics (41.1%) followed by 
supraventricular ectopics (29.4%). Out of 47 patients with inferior wall myocardial 
infarction only 3 patients (17.64%) had ventricular tachycardia, with 33.3%  of patients in 
each group. 
Table No. 14 
R/Q Ratio and Ejection Fraction in Thrombolyzed and Non Thrombolyzed in 
Inferior Wal1 Myocardial Infarction 
 
S. N. IWMI (n-47) R/Q Ratio Ejection Fraction 
   (Mean±S.D.) (Mean±S.D.) 
 1. Thrombolyzed (n-26) 2.89±1.54 48.84±5.56 
 2. Non-thrombolized (n-21) 1.89±1.0 46.89±6.78 
t=2.57  p<0.05  Significant (Thrombolysed) 
t=4.19  p<0.001 Highly Significant (Non Thrombolysed) 
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There is statistically significant difference in mean R/Q ratio and EF in 
thrombolysed and non thrombolysed patients of inferior wall myocardial infarction. 
 
Table No. 15 
Relationship of Change in R/Q Ratio with Thrombolysis 
 
Changes in R/Q Ratio Thrombolyzed Non-thrombolyzed 
 from 3rd to 7th Day (n-26) (n-21) 
  No. % No. % 
 Increase in R/ Q Ratio - - - - 
 No Change in R/Q Ratio 22 84.61 13 61.10 
 Decrease in R/Q Ratio 4 15.35 8 38.09 
Chi square=9.92 p<0.05  Significant 
 
 
Out of 26 patients of inferior wall myocardial infarction thrombolyzed 22 
patients (84.61 %) had no change in R/Q ratio from 3rd day to 7th day. But 4 patients 
(15.35%) showed a decrease in R/Q ratio on 7th day as compared to R/Q ratio on 3rd 
day. In non-thrombolyzed patients of IWMI 8 patients (38.09%) showed a decrease in 
R/Q ratio on 7th day as compared to R/Q ratio on 3rd day. So significantly less 
number of patients showed decrease in R/Q ratio in thrombolyzed as compared to non-
thrombolyzed patients. 
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Table No. 16 
R/Q Ratio and Regional Wall Motion Abnormalities (RWMA) 
 
RWMA Group I  Group II Group III 
 (>2)   (1-2)  «1) 
 No. % No. % No. % 
Hypokinesia (n-22) 14 63.64 6 31.57 2 66.67 
Akinesia (n-21) 7 31.8 13 68.43 1 33.3 
Normal (n-1) 1 4.54 - - - - 
Total (n-44) 22 100.0 19 100.0 3 100.0 
*3 patients of IWMI expired befor Echocardiography. 
Chi square=10.23 p<0.05  Significant (I vs III) 
Chi square=12.99 p<0.05  Significant (II vs III) 
Chi square=25.69 p<0.001 Highly Significant (I vs II) 
 
Out of 22 patients in group I, 14patients (63.64%) had hypokinesia and 7 patients 
(31.8%) had akinesia of inferior segment of left ventricle. Out of 44 patients of IWMI; 22 
patients had hypokinesia in which 14 patients (63.64 %) belonging to group I; only 2 
patients (9.0%) belonged to group III. 
 
Table No. 17 
R/Q Ratio in Lead II and Ejection Fraction in IWMI 
 
S. No. RlQ Ration in Lead II No. of Cases Mean Ejection Fraction 
1. Group I (> 2) 22 49.91±5.99 
2. Group II (1-2) 21 46.10±5.84 
3. Group III (< 1) 4 42±6.32 
t=2.41  p<0.05  Significant (I vs III) 
t=2.11  p<0.05  Significant (I vs II) 
t=1.27  p>0.05  Insignificant (II vs III) 
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Among the various groups, maximum mean ejection fraction was reported in 
group I i.e. R/Q > 2. Lowest mean ejection fraction was in patients with R/Q ration < 1 
(group III). 
 
 
Table No. 18 
Killip Class and Distribution of Cases in IWMI 
 
Killip 
Group I Group II Group III 
(R/Q> 2) (R/Q 1-2) (R/Q < 1) 
Class 
 No. % No. % No. % 
I ( n=32) 17 77.2 12 57.0 3 75.0 
II (n=10) 4 18.18 6 28.5 - - 
III (n=4) 1 4.54 3 14.28 - - 
IV (n=1) - - - - 1 25.0 
Total 22 100.0 21 100.0 4 100.0 
(n=47)       
Chi square=70.23  p<0.001 Highly Significant (Gr I vs Gr III) 
Chi square=10.36  p<0.05  Significant(Gr I vs Gr II) 
 
Out of 32 cases of Killip class 117 (53.12%) patients from Group I and 3 (9.37%) 
patients are from group III. Only one case of Killip class IV was reported from the 
present study, which was from group III. Majority of group II patients were in Killip 
class I and II (85.5%). 
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Table No. 19 
Killip Class with Mean R/Q Ratio and Ejection Fraction in IWMI 
 
Killip Class Mean R/Q Ratio Mean Ejection Fraction 
I 2.66 ±1.49 49.55 ±5.22 
II 2.19 ±1.02 46.64 ±6.61 
III 2.0 ±1.73 40.0 ±5.29 
IV 0 38 
       r =-1.0, insignificant  r = -1.0, insignificant 
Mean R/Q ratio of Killip class I was 2.66 ±1.49 against 2.0 ±l.73 in Killip class 
III. Mean ejection fraction of Killip class I was 49.55 ±5.22 and 40.0 ±5.29 in Killip class 
III. There was a weak correlation between mean R/Q ratio and mean ejection fraction 
with Killip class. 
 
Table No. 20  
Comparison of R/Q Ratio and QRS Duration in Relationship to Ejection Fraction 
 
S.No. R/Q Ratio Mean Ejection      QRS Duration Mean Ejection
  Fraction  Fraction 
1. Group I (> 2) 49.91 ±5.99 Group A (< 0.09) 48.96 ±6.53 
2. Group II  (1-2) 46.10 ±5.84 Group B (0.09 - 0.11 ) 40.94 ±3.90 
3. Group III (<1) 42 ±6.32 Group C (> 0.11) 43.17 ±4.83 
Mean ejection fraction of group I was 49.91 ±5.99 and group A 
was 48.86 ±6.53. Mean ejection fraction of group III was 42 ±6.32 and in group C it 
was 43.17 ±4.83, as R/Q decreases the reduction in mean ejection fraction was also 
significant. Similar to this prolongation of QRS duration also correlates with 
decrease in mean ejection fraction. Intermediate QRS duration prolongation (0.09-
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0.11) in Group B had lowest mean ejection fraction. 
 
 
Table No. 21 
Correlation of R/Q Ratio Groups with QRS Duration Groups in IWMI 
 
R/Q Ratio No .of QRS Duration No. of % 
  Patients  Patients  
   Group A «0.09) 20 90.90 
 Group I 
22 Group B (0.09-0.11) 2 9.10 
 (R/Q> 2) 
   Group C (>0.11) 0 0 
   Group A (>0.09) 11 52.4 
 Group II 
21 Group B (0.09-0.11) 5 23.80 
 (R/Q 1- 2) 
   Group C (>0.11) 5 23.80 
   Group A (<0.09) 1 25.0 
 Group III 
4 Group B (0.09-0.11) 2 50.0 
 (R/Q < 1) 
   Group C (>0.11) 1 25.0 
 
Percentage of patients with QRS duration < 0.09 sec was 90.90% in group I, 
52.40% in group II and 25% in group III. 
 
In group III (R/Q<l) 25% patients belong to group A and 25% belong to group 
C and none of patients in group I had QRS duration> 0.11 sec. 
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DISCUSSION 
The present series “Study of QRS Duration and R/Q Ratio in the Assessment of 
Severity of Acute Myocardial Infarction” was carried out on 75 patients admitted in 
ICCU of Department of Medicine, Government Royapettah Hospital, Kilpauk Medical 
College, Chennai-10. 
For the study of “QRS Duration” in the severity of myocardial infarction (both 
AWMI and IWMI) patients were divided into 3 groups. 
Group A With QRS duration < 0.09 Sec. 
Group B With QRS duration 0.09 - 0.11 see (intermediate QRS prolongation) 
Group C With QRS duration > 0.11 see (Significant QRS prolongation) 
For the study; patients of inferior wan myocardial infarction were divided into 3 
groups according to “R/Q ratio” in lead II on 3rd day. 
Group I Includes patients of IWMI with R/Q ratio> 2 
Group II  Includes patients of IWMI with R/Q ratio 1- 2 
Group III  Includes patients of IWMI with R/Q ratio < 1 
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TYPE OF MYOCARDIAL INFARCTION 
In the present study 44 patients (58.67%) were having inferior wall myocardial 
infarction 28 patients (37.33%) were having anterior wall myocardial infarction and 3 
(4.0%) were having both anterior and inferior wall myocardial infarction. 
DISTRIBUTION OF EJECTION FRACTION 
In the present study 34.61% of anterior wall myocardial infarction patients were 
having LVEF of < 40% as compared to 17.07% of patients of inferior wall myocardial 
infarction. The percentage of patients of anterior wall myocardial infarction with ejection 
fraction of > 50% was only 15.38% as compared to 31.07% in inferior wall myocardial 
infarction. So statistically significant lower ejection fraction in anterior wall myocardial 
infarction as compared to IWMI (p< 0.001) was seen. 
The observation was similar to that of Mark et al (1987) (53) who observed that 
there is greater left ventricular involvement and dysfunction in patients with anterior 
myocardial infarction of equivalent enzymatic size. 
Eaton et al (1979) (54) in a limited series of 28 patients showed that anterior 
infarcts are more at risk of expanding with thinning of the infarct zone combined with 
acute regional dilatation than inferior infarcts. It is anticipated that this process would 
lead to greater left ventricular regional wall motion abnormality both at rest and during 
exercise. 
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Strass et al (1980) (55) observed that there was greater involvement and reduced 
function of the left ventricle in patients with anterior infarction compared to those with 
inferior infarction of equivalent enzymatic size. 
QRS DURATION AND DISTRIBUTION OF MYOCARDIAL INFARCTION: 
In the present study most of the patients of inferior as well as anterior wall 
myocardial infarction were distributed in group A (QRS < 0.09 sec.) 40% of AWMI 
patients were having QRS duration > 0.09 seconds as compared to 30% of patients in 
IWMI (p<0.05). 
QRS DURATION AND ARRHYTHMIA IN MYOCARDIAL INFARCTION: 
Ventricular ectopics were the most common arrhythmia observed in relationship 
to QRS duration groups. Maximum incidence of ventricular tachycardia (44.44%) was in 
group B (QRS 0.09-0.11 sec.). Out of the 8 patients in group C (QRS > 0.11 sec) 2 
patients were (25.0%) having ventricular tachycardia as com pared to 3 patients (6.38%) 
in group A (< 0.09 sec.) so statistically significant high incidence of malignant 
arrhythmias was noted in patients of intermediate QRS prolongation (0.09 - 0.11 sec) and 
significant QRS prolongation (> 0.11 see) in the present study. 
Previous study by Pudil et al (2001) (38) showed that in hospital complication 
including asystole, ventricular tachycardia, ventricular fibrillation, congestive heart 
failure were more common among patients with prolonged QRS duration. 
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Prolonged QRS duration was a significant predictor of sustained monomorphic 
VT inducibility (p<0.00l) (Relative risk 3.290, 95% confidence interval 2.185 to 4.953 
for prolonged vs normal QRS duration) (44). 
At multivariate analysis, only low left ventricular ejection fraction, prolonged 
QRS duration, reduced heart rate variability index, and detection of approximately 2 runs 
of unsustained VT per monitoring had an independent relation to late arrhythmic events 
(45). 
REGIONAL WALL MOTION ABNORMALITY AND EJECTION FRACTION IN 
RELATION TO QRS DURATION: 
In the present study akinesia was reported from 14 patients (87.5%) of group B 
(0.09 - 0.11 sec.), 4 patients (66.67%) of group C (> 0.11 see) and 24 patients (50%) of 
group A « 0.09 see); hypokinesia was reported from 2 patients (12.5%) of group B, 2 
patients of group C (33.33%) and 22 patients (46.0%) of group A. Hence, regional wall 
motion abnormality was having a significant relationship with QRS duration. Increased 
QRS duration had an increased incidence of akinesia in the present study (p< 0.001). 
In the present study patients with ejection fraction of >50% in group A was 
35.42% in group C 16.67%. None of the patients in Group B was having ejection fraction 
of> 50%. 
In a previous study by Brilakis et al (46) QRS duration> 100 msec on standard 12 
lead ECG was a specific indicator of left ventricular dysfunction (EF< 45%). 
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In 27 out of 28 postmyocardial patients in whom left ventricular systolic 
dysfunction (defined as ejection fraction of < 40%) developed; QRS duration increased 
from 107±12 milliseconds to128±18 milliseconds. 
Pudil et al (2001) (38) showed that a QRS of <0.09 sec on admission 
electrocardiogram is indicative of a relatively benign outcome compared with a QRS of 
>0.09 sec. Patients with intermediate QRS prolongation (0.09 - 0.11 sec.) also associated 
with decreased ejection fraction and increased incidence of akinesia. Hence intermediate 
QRS duration prolongation had also statistically significant relationship with ejection 
fraction and RWMA in a similar way to significant QRS prolongation (> 0.11 sec.). 
QRS DURATION AND KILLIP CLASS: 
In the present study in group A (< 0.09 sec.) 71.4% (n=35) of patients were 
belonging to Killip class I as compared to 12.5% in group C. Patients with Killip class> 
II were 4% in group A, 62.5% in group C and 16.6% in group B. These results are 
statistically significant (p< 0.05). 
In the present study mean QRS duration of class I patient was 0.08±0.01 as 
compared to 0.10 in Killip class IV. As Killip class of patient increases mean QRS 
duration also increases. 
Above observations go in agreement with previous study by Brilakis et at (2002) 
(46) in which patients with QRS duration < 100 milliseconds to be in Killip class II, III or 
IV at presentation. Patients with QRS duration < 100 milliseconds, percentage of patients 
with Killip class> II was 16.7% against 32% in patients with QRS duration > 100 
millisec. 
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Michaelides et al (1993) (42) reported that exercise induced QRS prolongation 
was proportional to the number of coronary arteries with > 70% stenosis. Mean QRS 
prolongation was 4.8±7.5 milliseconds in patients with I-vessel disease, 7.8±11.8 
milliseconds in patients with 2-vessel disease and 13.3±12.1 milliseconds in patients with 
3-vessel disease. Study by Brilakis. et al (2002) (46) showed increased QRS duration was 
strongly associated with heart failure as evidenced by worse Killip class. 
MORTALITY IN RELATION TO QRS DURATION: 
In the present study, out of the 75 patients 6 (8.0%) expired.  One from group A 
(2.0%), 3 from group B (16.67%), and 2 (25.0%) from group C. In the mortality group, 
except one patient of AWMI rest of them expired before echocardiography could be 
done. So correlation with ejection fraction and R/Q ratio was not possible; hence 
mortality was analysed on the basis of QR5 duration. Analysis of present study data 
shows that increased QRS duration had a significant statistical relationship with mortality 
(p< 0.05). 
QRS duration measured on a standard ECG remains a powerful predictor of 
mortality after adjustment for ejection fraction and other clinical covariates. Data in a 
large population of post infarction patients indicates that QRS of 0.12 seconds is 
associated with hazard ratio of 1.7; p = 0.001. Above observations in the present study 
i.e; highest mortality 25% in group C patients (QRS > 0.11 sec.) is in agreement with the 
observations of Fadl et al (2003). (47) 
QRS duration remains a very powerful predictor of future cardiac events in post 
infarction patients. QRS duration reflects well the magnitude of left ventricular 
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dysfunction and therefore not surprisingly is a powerful predictor of mortality in post 
infarction patients. (40) 
In a previous study by Pudil et al (2001) (38) 7 day mortality of patients with 
QRS duration (<0.09 sec) was < l%, 6% in 0.09-0.011 see group and 18% in > 0.11 see 
group. So the present study observations go in agreement with the study of Pudil et al 
(2001) (38). 
R/Q RATIO AND COMPLICATIONS OF MYOCARDIAL INFARCTION 
In the present study statistically significant relation between R/Q ratio and 
complications of myocardial infarction was present. All patients of group III (R/Q < 1) 
were having different types of complications of myocardial infarction, 50% of them 
developed arrhythmia, 50% having raised JVP, and 25% having hypotension as 
compared to group I (> 2), where 31.8% of patients where having arrhythmia, 13.63 % 
having raised JVP and none of them had hypotension. 
In a previous study by Alexander Arditti et al (1985) (50) no patient with R/Q 
ratio> 2 developed signs of heart failure, compared to 2 patients in group II (R/Q ratio 1-
2) and 4 patients in group In (R/Q ratio < 1). 
In another study by Eliezer Klainman et al (1988)(51) showed that clear tendency 
for more incidence of complications of myocardial infarction in group III (R/Q ratio < 1) 
as compared to group I (R/Q ratio> 2). 
In the present study the most common arrhythmia reported was ventricular 
ectopics (41.1%) followed by supraventricular ectopics (29.41 %). 
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Out of the 47 patients of inferior wall myocardial infarction only 3 patients 
(6.38%) were having ventricular tachycardia with equal percentage of patients in each 
group. 
These findings go in agreement with Alexander Arditti et al (1985)(50) in that 
there were no statistical differences between three groups of inferior wall myocardial 
infarction in the incidence of ventricular tachycardia and other arrhythmias. Ventricular 
tachycardia was reported in 5 patients out of 39 in R/Q > 2 group and 5 patients out of 29 
in R/Q < 1 group. 
Data from Gusto I trial indicates that in thrombolytic era sustained VT occurs in 
3.5% of patients, ventricular fibrillation in 4.1% of patients and a combination of 
sustained ventricular tachycardia and ventricular fibrillation in 2.7% of patients. 
Statistically significant relation between R/Q ratio and mean ejection fraction was 
seen in the present study. Mean ejection fraction of patients with R/Q ratio> 2 (group I) 
was 49.91±5.99, 46.10±5.84 in patients with R/Q ratio 1-2 (group II) and 42 ±6.32 in 
patients of R/Q ratio < 1 (group III). 
In the previous study by Alexander Arditti et al (1985) (50) mean ejection fraction 
in group III (R/Q ratio<1) was 51.50±9.40 as compared to mean ejection fraction 
60.15±8.90 in group I (R/Q ratio>2). Intermediate group was having mean ejection 
fraction of  51.20±16.50. 
In 1974 Miller et al (56) demonstrated that, the presence of a pathologic Q wave 
was a specific indicator of dyssynergy and that the sensitivity of a QRS complex for 
predicting wall motion abnormalities increased with severity of dyssenergy. ldekar et al 
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(1978 )(57) examined the histopathological findings in 24 patients with ischemic heart 
disease and dyssynergy demonstrated by contrast ventriculography. They noted that the 
degree of dyssynergy was directly related to the percentage of fibrosis and the percentage 
of the total left ventricle occupied by fibrotic tissue was significantly related to Global 
left ventricular ejection. 
R/Q RATIO AND REGIONAL WALL MOTION ABNORMALITIES: 
In the present study, out of 22 patients in group I (R/Q ratio>2), 14 patients 
(63.64%) were having hypokinesia and 7 patients (31.8%) were having akinesia of 
inferior segment of left ventricle. Out of the 44 patients of inferior wall myocardial 
infarction 22 patients were having hypokinesia in which 14 patients (63.64%) belonging 
to group I (R/Q ratio> 2) only 2 patients (9.0%) belonged to group III (R/Q ratio < 1). So 
present study shows that with good R/Q ratio i.e. > 2 severity of regional wall motion 
abnormality decreases. As R/Q ratio decreases, severity of regional wall motion 
abnormality increases. 
This finding is in agreement with the previous study of Alexander Arditti et al 
(1985) (50) which showed that group I (R/Q ratio. > 2) was notable only for the presence 
of hypokinesia of inferior wall; while other segments are minimally affected. Group II 
(R/Q ratio 1-2) showed a higher incidence of akinesia, group III (R/Q ratio < 1) showed 
higher incidence of akinesia of different segments of inferior wall of left ventricle. 
In Inferior wall myocardial infarction a QS complex is usually present in lead III 
and aVF, standard lead II usually reflects Qr and QR complex. In inferior wall 
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myocardial infarction, among the inferior leads tallest terminal ’R’ wave is seen in lead 
II. 
We can explain this distribution of terminal ‘R” wave by considering the anatomy 
of inferior wall. We can divide the inferior wall into right lateral and left lateral region. 
Lead III is oriented to right lateral region and lead II to left lateral region. The brunt of 
infarction affects the right lateral region of inferior wall with sparing of left lateral region. 
So lead III reflects the largest and widest QS complex. Lead II however is oriented to left 
lateral region of inferior wall reflects the potentials of healthy overlying muscle as a 
terminal ‘R’ wave. So loss of ‘R’ wave in lead II occurs mainly in extensive inferior wall 
myocardial infarction. So ampliitude of ‘Q’ and ‘R’ wave in lead II is a measure of 
severity of inferior wall myocardial infarction (48). 
KILLIP CLASS AND R/Q RATIO 
In present study, distribution of inferior wall myocardial infarction in relationship 
to Killip class was statistically significant. Out of 32 cases of Killip class I, 17 (53.12%) 
are from group I (R/Q ratio> 2) and 3 cases (9.37%) are from group III (R/Q ratio < 1). 
Only one case of Killip class IV was reported from the present study, which was from 
group III (R/Q ratio < 1). Majority of group II (R/Q ratio 1-2) patients are in Killip class I 
and II (85.5%). (p < 0.05). 
In the previous study by Eliezer Klainman et al (1988) (51) showed that on 
decrease of R/Q ratio in lead II, Killip class was on rising trend. Study by Alexander 
Arditti et al (1985) (50) showed that in a group of inferior wall myocardial infarction 
with R/Q ratio>2, majority of the patients were in Killip class I, none developed 
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congestive heart failure. In patients with R/Q ratio 1-2 majority of patients are in Killip 
class I and II. Patients with R/Q ratio < 1, majority of patients were in Killip class II and 
III. 
RATIO AND THROMBOLYSIS IN IWMI: 
Present study shows that there is a statistically significant difference in R/Q ratio 
in thrombolyzed and non thrombolyzed patients of inferior wall myocardial infarction 
(p< 0.05). 
Out of 26 patients of inferior wall myocardial infarction thrombolyzed 22 patients 
(84.61%) had no change in R/Q ratio on 7th day compared to 3rd day, 4 patients 
(15.35%) showed a lower R/Q ratio on 7th day as compared to 3rd day of hospitalisation. 
But in non-thrombolyzed cases of inferior wall myocardial infarction 8 patients 
(38.09%) had a lower R/Q ratio on 7th day as compared to R/Q ratio on 3rd day. So these 
results show that lower R/Q ratio on 7th day in non-thrombolyzd patients as compared to 
thrombolyzed patients of inferior wall myocardial infarction was statistically significant 
(p< 0.05). 
We can explain this observation in that, lead II is oriented to left lateral region of 
inferior wall and lead III to right lateral lesion. If proper thrombolysis was done, the brunt 
of infarction restricted to the right lateral region of inferior wall. SO R/Q ratio not 
decreases with time because thrombolysis prevent the extend of infarction to left lateral 
region and reflects the potentials of healthy overlying muscle as a terminal ‘R’ wave but 
in non thrombolysed patients extend of infarction occurs with loss of ‘R’ wave and 
development of ‘Q’ wave. 
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MEAN EJECTION FRACTION IN RELATION TO R/Q AND QRS DURATION: 
In the present study mean ejection fraction of group I (R/Q ratio> 2) was 
49.91±5.99 and group A (QRS duration < 0.09 seconds) was 48.86±6.53. Mean ejection 
fraction of group III (R/Q ratio < 1) was 42±6.32 and in group C (QRS duration> 
0.11sec) it was 43.17±4.83. As R/Q decreases; statistically significant reduction of mean 
ejection fraction also occurs. Similar to this, prolongation of QRS duration also correlates 
with decrease in mean ejection fraction. Intermediate QRS prolongation (0.09 - 0.11secs) 
i.e. group B were having lowest mean ejection fraction. 
In previous study by Alexander Arditti et al (1985) (50) mean ejection fraction 
was 60.15±8.90 in patients with R/Q ratio>2 and as R/Q decreases to < 1 mean ejection 
fraction decreased to 51.50±9.40. Horwich et al, (2003) (44) showed that patients with 
prolonged QRS duration had lower left ventricular ejection fraction. 
Study by Pudil et al (2001) (38) showed that similar to significant QRS duration 
prolongation (> 0.11 sec.); intermediate QRS duration prolongation (0.09 - 0.011 sec.) on 
surface electrocardiograms was associated with left ventricular dysfunction. Murkofsky 
et al (1998) (40) showed that QRS duration> 0.1 sec was associated with decreased left 
ventricular ejection fraction. 
DISTRIBUTION OF QRS DURATION GROUPS IN R/Q RATIO GROUPS IN 
INFERIOR WALL MYOCARDIAL INFARCTION: 
Out of 22 patients of group I (R/Q ratio> 2) 90% of patients are in group A (QRS 
< 0.09 sec.), none of them had QRS duration > 0.11 sec (Group C). But in group III (R/Q 
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ratio < 1) 25% patients are of group A (< 0.09 sec.) and 25% are of group C (> 0.11 sec.). 
These results shows that as R/Q ratio decreases from> 2 in group I to < 1 in group IIII 
percentage of distribution of patients with QRS prolongation increases (> 0.09 see.) and 
patients with normal QRS duration (<0.09 sec) decreases. So the above results are 
statistically highly significant (p< 0.001). Analysis of present study shows that both 
lower R/Q ratio in lead II and prolonged QRS duration signifies the extent of inferior 
myocardial infarction. So estimation of R/Q ratio in lead II or QRS duration; in standard 
12 lead ECG serves as an extremely useful tool in the risk stratification after inferior 
myocardial infarction. 
 66
SUMMARY AND CONCLUSION 
The present series “Study of QRS Duration and R/Q Ratio in the Assessment of 
Severity of Acute Myocardial Infarction” was carried out on 75 patients admitted in the 
ICCU of Department of Medicine, Government Royapettah Hospital, Kilpauk Medical 
College, Chennai -10. 
For the study of “QRS Duration” in the severity of myocardial infarction (both 
AWMI and IWMI) patients were divided into 3 groups. 
Group A    With QRS duration < 0.09 Sec. 
Group B    With QRS duration 0.09 - 0.11 sec (intermediate QRS prolongation) 
Group C    With QRS duration > 0.11 sec (Significant QRS prolongation) 
For the study; patients of inferior wan myocardial infarction were divided into 
groups according to “R/Q ratio” in lead II on 3rd day. 
Group I  Includes patients of IWMI with R/Q ratio> 2 
Group II  Includes patients of IWMI with R/Q ratio 1- 2 
Group III  Includes patients of IWMI with R/Q ratio < 1 
The patients were selected after application of the following exclusion criteria - 
patients with ECGs, showing evidence of LBBB, RBBB, LAHB, LVH, old myocardial 
infarction, pacemaker dependence.  
 67
(1) In the present study 34.61% of anterior wall myocardial infarction were having 
LVEF of < 40% as compared to 17.07% of patients of inferior wall myocardial 
infarction. The percentage of patients of anterior wall myocardial infarction with 
ejection fraction of> 50% was only 15.38% as compared to 31.07% in inferior 
wall myocardial infarction so statistically significant lower ejection fraction in 
anterior wall myocardial infarction as compared to IWMI. 
(2) Ventricular ectopics were the most common arrhythmia observed in relationship to 
QRS duration groups. Maximum incidence of ventricular tachycardia (44.44 %) 
was in group B (QRS 0.09-0.11 sec.). Out of the 8 patients in group C (QRS > 
0.11 sec.) 2 patients were (25.0%) having ventricular tachycardia as compared to 
3 patients (6.38%) in group A (<0.09 sec) so statistically significant high 
incidence of malignant arrhythmias in patients of intermediate QRS prolongation 
(0.09 - 0.11 see) and significant QRS prolongation (> 0.11 see) was noted in the 
present study. 
(3) Akinesia was reported from 14 patients (87.5%) of group B (0.09 - 0.11 sec.), 4 
patients (66.67%) of group C (> 0.11 see) and 24 patients (50%) of group A « 
0.09 see); hypokinesia was reported from 2 patients (12.5%) of group B, 2 
patients of group C (33.33%) and 22 patients (46.0%) of group A. Hence, regional 
wall motion abnormality had a statistically significant relationship with QRS 
duration. Increased QRS duration had an increased incidence of akinesia in the 
present study (p< 0.001). 
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(4) Statistically significant relationship was present between ejection fraction and QRS 
duration in the present study Patients with ejection fraction of> 50% in group A 
was 35.42% and in group C, it was 16.67%. 
(5) In the present study in group A 71.4 % of patients were belonging to Killip class I as 
compared to 12.5% in group C. Patients with Killip class> II were 4% in group A 
62.5% in group C and 16.6% in group B. 
(6) Mean QRS duration of class I patients was 0.08±0.01 as compared to 0.10 in Killip 
class IV. As Killip class of patient increases mean QRS duration also increases. 
So the present study demonstrated that there was a statistically significant relation 
between QRS duration and Killip class of myocardial infarction. 
(7) Mean ejection fraction of group A (<0.09 seconds) patients was 48.86±6.53, 
40.94±3.90 in group B and 43.17±4.83 in group C, so both intermediate and 
significant QRS prolongation was having decreased mean ejection fraction so 
intermediate QRS prolongation is as significant as that of significant QRS 
prolongation in assessing LV function. 
(8) In the present study statistically significant relation between R/Q ratio and 
complications of myocardial infarction was present. All patients of group III (R/Q 
< 1) were having different types of complications of myocardial infarction, 50% 
of them developed arrhythmia, 50% having raised JVP, and 25% having 
hypotension as compared to group I (> 2), where 31.8% of patients where having 
arrhythmia, 13.63% having raised JVP and none of them had hypotension. 
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(9) In the present study in inferior wall myocardial infarction most common arrhythmia 
reported was ventricular ectopics (41.1 %)  followed by supraventricular 
ectopics (29.4%). Out of the 47 patients of inferior wall myocardial infarction 
only 3 patients (6.38%) were having ventricular tachycardia with equal 
percentage of patients in each group. 
(10) Statistically significant relationship between R/Q ratio and mean ejection fraction 
was seen in the present study. Mean ejection fraction of patients with R/Q ratio> 2 
(group 1) was 49.91±5.99, 46.10±5.84 in patients with R/Q ratio 1-2 (group II) 
and 42.0±6.32 in patients of R/Q ratio < 1 (group III) 
(11)  Out of the 22 patients in group I (R/Q ratio> 2), 14 patients (63.64 %) were 
having hypokinesia and 7 patients (31.8%) were having akinesia of inferior 
segment of LV. Out of the 44 patients of inferior wall myocardial infarction 22 
patients were having hypokinesia in which 14 patients (63.64 %) belonging to 
group I (R/Q ratio> 2) only 2 patients (9.0%) belonged to group ill (R/Q ratio < 
1). So present study shows that with good R/Q ratio i.e. > 2 severity of regional 
wall motion abnormality decreases. 
(12)  In present study distribution of inferior wall myocardial infarction in. relationship 
to Killip class was statistically significant. Out of 2 cases of Killip class 1, 17 
(53.12%) are from group I (R/Q ratio> 2) and 3 cases (9.37%) are from group III 
(R/Q ratio <1). Only one case of Killip class IV was reported from the present 
study, which was from group III (R/Q ratio < 1). Majority of group II (R/Q ratio 
1-2) patients are in KiI1ip class I and II (85.5%). 
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(13)  Out of 26 patients of IWMI thrombolyzed, 22 patients had no change in R/Q ratio 
on 7th day as compared to 3rd day, 4 patients showed a lower R/Q ratio on 7th 
day. But in non thrombolyzed cases of IWMI 8 patients had a lower R/ Q ratio on 
7th day as compared to 3rd day. So lower R/Q ratio on 7th day in nonthrombolized 
patients as compared to thrombolyzed patients of IWMI was statistically 
significant. Successful thrombolytic therapy will prevent the extent of inferior 
wall myocardial infarction. 
(14)  Out of 22 patients of group I (R/Q ratio> 2) 90% of patients are in group A, none 
of them had QRS duration> 0.11 sec (group C). But in group III (R/Q ratio < 1) 
25% of patients are of group A, and 25% are of group C. As R/Q ratio decreases 
from > 2 in group I to <1 in group III, percentage of distribution of patients with 
QRS prolongation (> 0.09 see.) increases and patients with normal QRS duration 
(< 0.09 see.) decreases. These results are statistically highly significant. 
(15)  In the present study, out of the 75 patients 6 (8.0%) expired. One from group A 
(2.0%), 3 from group B (16.67%) and 2 (25.0%) from group C. In the mortality 
group except one patient of AWMI rest of them expired before echocardiography 
could be done. So correlation with ejection fraction and R/Q ratio was not 
possible. Hence mortality was analysed on the basis of QRS duration. Analysis of 
present study data shows that increased QRS duration had a significant statistical 
relationship with mortality (p< 0.05). 
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CONCLUSION 
The present study shows that the estimation of QRS duration in patients of acute 
myocardial infarction offer important indirect quantitative information regarding the 
severity and extent of myocardial infarction. A QRS duration of > 0.09 sec predicts more 
incidence of arrhythmia, heart failure and other complications. This study shows that both 
intermediate QRS prolongation (0.09 - 0.11 see.) and significant QRS prolongation (> 
0.11 sec) is an eye-opener to worse short term prognosis of myocardial infarction. The 
current study also concludes that QRS duration < 0.09 seconds is indicative of a 
relatively benign short term outcome. 
The present study also shows that the estimation of the R/Q ratio in lead II of 
patients with IWMI offers important indirect information regarding the severity and 
extension of the myocardial damage. An R/Q ratio of > 2 predicts mild localised LV 
involvement with good global LV function and good clinical course. An R/Q ratio of 
between 1 and 2 predicts a greater degree of local asynergy and reduced LV function, but 
still a good clinical outcome. Finally, R/Q ratio of < 1 predicts severe inferior wall 
asynergy with reduced LV function and complicated clinical course. Current study also 
indicates that successful thrombolytic therapy will prevent the extent of inferior wall 
myocardial infarction. 
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S.no Name Age Sex R/U Rel   Presenting Symptoms Past History          Per his             General Examination              Resp. Sy
C.P Swe. Nau. Vom. Sync. Breath Palp. H.T. D.M H.D       Addic Diet Ht Wt BMI B.P. JVP      Basal Crep
T S A Sys Dias
1 B.K 60 M R H 3.00AM + + + - - - + - - - - - V 1.7 50 17.3 60 + +
2 G.S 55 M R H 6.3AM + + + - - - - - - + + - V 1.68 70 24.8 150 90 - -
3 S.T 65 F U H 12.3PM - - + - - - - + - - - - V 1.5 56 24.89 110 76 - +
4 S.D 74 F R H 4.00AM - - - - - - - + - + - - V 1.72 51 17.24 130 80 - +
5 S.D 40 M R H 6.3PM + - - - + - - - - + - - V 1.6 60 23.44 110 76 - -
6 R.P 80 M U H 7.3AM + - + - + - - - - - - - V 1.73 74 24.73 60 - + +
7 R.L 60 M U H 5.00AM + - - - - - + - - + - - V 1.6 52 20.31 110 70 + +
8 R.B 45 M R H 1.3PM + - - - - + - - - + + - V 1.67 58 20.8 100 80 + -
9 G.S 75 M R M 7.3PM + + - - + - - - - + - - V 1.72 72 24.34 140 80 + +
10 S.M 68 M R H 6.00AM + - - - - - + - - + + - V 1.74 70 23.12 126 80 + -
11 R.K 61 M R H 8.3AM + + - - + - - + - + - - M 1.5 60 26.67 130 80 + +
12 A.B 95 M U H 2.00AM + + - - + - - - - + + - V 1.68 74 26.22 84 60 - +
13 R.B 73 F U H 8.3PM + - - - - - + - - - + - V 1.7 52 17.99 100 70 - +
14 P.S 42 M U H 1.00AM + + + - + - - + - + + - M 1.78 85 26.83 - - - +
15 M.H 70 M R M 9.3AM + - - - + - - - - + + - V 1.74 72 23.78 120 80 - +
16 J.P 72 M R H 1.3AM + - - - - - - - - - - - M 1.76 72 23.24 130 86 - -
17 R.P 72 M R H 9.3PM + - - - + - - - - - - - V 1.86 85 27.28 110 70 - -
18 J.P 70 M R H 10.3AM + - - - + - - - - + - - V 1.56 68 27.94 110 80 + -
19 U.P 60 M R H 2.3AM + - - - - - - - - + - - M 1.68 68 24.09 130 70 + -
20 K.P 50 M U H 2.3AM + - - - - - - - - + - - V 1.62 65 24.77 110 80 + -
21 D.S 52 M R H 3.3AM + - - - - - - - - + - - M 1.72 76 25.69 100 80 + -
22 B.L 60 M U H 10.3PM + - - - - - - - - + - - V 1.62 78 29.72 130 90 + -
23 R.P 82 M R H 11.3PM + - - - - - + + - - - - V 1.68 82 29.05 130 80 - -
24 R.N 65 M R H 4.3AM + - - - + - - - - + + - V 1.5 62 27.56 80 60 - +
25 I.K 65 M U M 11.3AM + - - - - - - + - + + - V 1.6 68 26.56 120 80 - +
26 S.L 65 M U H 7.00PM + - - - - - - - - + + - V 1.61 76 29.3 138 80 - +
27 I.W 55 F R H 5.3AM + - - - - - - - - + + - V 1.58 60 24.03 110 80 - +
28 R.G 42 M U H 7.00AM + - + - - - - - - + + - V 1.7 68 23.23 130 80 - -
29 M.L 65 M R H 3.3PM - - - - - - + - - + - - V 1.75 54 17.63 134 90 - -
30 R.W 40 M R H 7.00AM + - - - - - - - - + - + V 1.68 78 27.64 120 80 - -
31 H.K 60 M R M 1.00AM + - + - - - - + - + - + V 1.68 62 21.97 140 70 - -
32 R.A 65 M U H 8.00PM + - - - - - - - - - + - V 1.56 58 23.83 140 120 - +
33 K.W 55 F R H 2.00AM - - - - - - - - - + + - M 1.64 60 22.31 100 70 - +
34 N.M 62 M R H 8.00AM + - + - - - + + - + + - V 1.6 72 28.13 200 80 - +
35 M.N 50 M R H 3.00AM - - + - - - - - - - + - V 1.7 53 18.34 110 80 - -
36 D.S 35 M U H 3.3PM + - - - - - - - - + - - V 1.72 66 22.3 140 80 - -
37 R.J 60 M R H 4.00AM + - + - - - - - - + + - V 1.62 60 22.86 124 80 - -
yst.
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S.NO.         Investigation                    T/t Given                Arrthythmia             E.C.G.              ECHO Diagnosis Outcome
Hb TLC B.S. B.U. S.Cho SK Dose Anti.Insch Ant.Coau. S.V.E. V.E. S.V.T V.T C.H.B      R/Q Ratio QRS Duration E.F. Wall Motion
3 Day 7Day
38 11.5 5600 80 34 190 - + + - - - - - 3 2.5 0.06 52 HYPO.IW IWMI D
39 12 8800 78 32 SK 15 + + - - - - - 4 4 0.08 45 AKINA.IW IWMI D
40 11 9900 80 26 - + + - - - - - 1 0 0.08 44 AKINA.IPW IWMI D
41 11.5 10600 116 30 - + + - - - - - - 0.1 40 INA.IVS.APEX AWMI D
42 8.9 10600 74 32 SK 15 - - - - - - - - 0.08 48 AKINA.ILW AWMI D
43 9.8 9600 112 36 180 - + + - - - - - - 4 0.06 44 YPO.IVS.APEX AWMI D
44 10.6 9400 74 38 170 - + + - - - - - 4 3 0.08 40 AKINA.IVW IWMI D
45 8.8 10100 118 34 250 SK 15 + + - - - - - 5 0.06 52 HYPO.IVW IWMI D
46 9 11600 120 26 190 - + + - - - - - - 0.09 45 INA.IVS.APEX AWMI D
47 9.4 9800 116 30 180 SK 15 + + - - - - - 1.25 1.25 0.1 46 AKINA.IW IWMI D
48 8.2 10200 86 30 230 SK 15 + + - + - - - 2.5 2.5 3.08 48 HYPO.IW IWMI D
49 10.2 9600 80 26 180 SK 15 + + - - - - - 1 0 0.12 44 AKINA.ILW IWMI D
50 11 10100 78 34 180 - + + - - - - - 2 2 0.08 54 AKINA.IW IWMI D
51 9.8 9600 120 30 210 - + + - + - - - 1 1 0.08 54 AKINA.IW IWMI D
52 10.6 9400 122 32 212 - - + - - - - - 1 0 0.08 36 AKINA.IW,IVS IWMI D
53 9.8 9600 116 34 170 SK 15 + + - + - - - 1 1 0.08 49 HYPO.IW IWMI D
54 10.6 9400 70 30 190 SK 15 + + - + - - - - 0.08 48 AKIN.IVS AWMI D
55 11 9500 76 32 240 SK 15 + + - - - VT - - 0.1 32 .IVS.APEX.ALW AWMI D
56 8 10600 116 32 150 SK 15 + + - + - VT - - 0.08 45 .IVS.APEX.ALW AWMI D
57 8 9800 78 32 240 SK 15 + + - - - - - - 0.06 50 .IVS.APEX.ALW AWMI D
58 8 10600 72 3 220 SK 15 + + - + - - - - 0.08 44 .IVS.APEX.ALW AWMI D
59 11 9860 80 32 180 SK 15 + + - - - - - 3 3 0.08 48 AKIN.IW IWMI D
60 10.1 5600 78 28 110 - + + - + - - - - 0.1 40 .IVS.APEX.ALW AWMI D
61 10.6 9400 80 30 230 SK 15 + + - - - - - 2.5 2.5 0.06 50 AKIN.IW IWMI D
62 11 9500 116 28 250 SK 15 + + - + - - - 4 4 0.06 50 HYPO.IW IWMI D
63 8 10600 74 30 190 SK 15 + + - - - AIVR - 3 3 0.08 50 AKIN.IW IWMI D
64 8 9800 112 28 255 SK 15 + + - - - - - - 0.08 41 .IVS.APEX.ALW AWMI D
65 8 10600 116 40 235 SK 15 + + - + - - - - 0.06 48 .IVS.APEX.ALW AWMI D
66 11 9860 70 36 225 - + + - + - - - - 0.12 40 AKIN.IVS AWMI D
67 10.1 8600 76 28 170 SK 15 + + - - - - - - 0.1 44 .IVS.APEX.ALW AWMI D
68 10.6 9400 116 30 215 SK 15 + + - + - AVIR - 4 4 0.1 38 AKIN.IW.IVS IWMI+AWM D
69 11 9500 78 28 190 - + + - - - VT - 2 2 0.08 48 HYPO.IW IWMI D
70 8 10600 72 34 250 SK 15 + + - + - - - 3 3 0.06 60 NORMAL IWMI D
71 8 9800 80 26 180 SK 15 + + - - - - - 0 0 0.08 38 AKIN.IPW IWMI D
72 8 10600 78 40 220 - + + - + - - - - 0.1 40 .IVS.APEX.ALW AWMI D
73 11 9860 80 36 170 - + + - + - - - - 0.08 42 .IVS.APEX.ALW AWMI D
74 10.1 8600 116 34 210 - + + - + - - - - 0.06 70 NORMAL AWMI D
75 12 7500 74 22 180 SK 15 + + - - - VT - - 0.1 42 .IVS.APEX.ALW AWMI D
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PROFORMA 
“STUDY OF QRS DURATIONAND R/Q RATIO IN THE ASSESSMENT OF                                       
SEVERITY OF ACUTE MYOCARDIALINFARCTION” 
 
Case No.:  IP No.:     DOA:  DOD/E: 
Name:  Age:   Sex:M/F Religion H/M/C 
Domicile: R/U 
Address 
Socio-economic Status 
PRESENTING SYMPTOMS 
Chest Pain  Time of onset  Duration Hrs. Mts. 
Site   Central / Epigastric / Left Sided / Back 
Character  Burning / Crushing / Gripping / Squeezing / Tightening 
Severity   Mild / Moderate / Severe 
Precipitating or Aggravating Factors: 
Relieving Factors: 
Other Symptoms 
Sweating:  Nausea:  Vomiting Syncope 
Breathlessness Palpitation  Oedema Abd. Distension 
PAST HISTORY 
Hypertension  D.M.   I.H.D.  Others 
FAMILY HISTORY 
 Diabetes Mellitus HTN CAD Others 
Father     
Mother     
Brother     
Sister     
 
PERSONAL HISTORY 
Addiction   Duration   Quantity 
Tobacco Chewing 
Smoking 
Alcohol 
Diet- Veg / Non-Veg / Mixed 
GENERAL EXAMINATION 
Built:  Thin/Normal/ Obese Wt. (Kg):  Ht. (Cm) BMI 
Pulse R Ry V Ch Syn. Vessel Wall Peripheral 
Pulse 
RFD 
        
 
JVP Ht. (Cm.) A X C V Y Others 
       
 
B.P.  Temp.   Pallor    Cyanosis 
Icterus   Oedema  Xanthoma/Xanthelasma 
 
SYSTEMIC EXAMINATION 
CVS Inspection: 
   Shape    Apex beat 
   Other Pulsation 
  Palpation: 
   Apex beat:  Thrill:  LPH 
   Epigastric Pulsation Palpable P2: 
  Auscultation 
 S1 S2 S3 S4 Murmur Other 
Sounds Systolic Diastolic 
Mitral         
Tricuspid        
Pulmonary        
Aortic        
 
RESP. SYSTEM.   Basal Crepts 
 
ABDOMEN 
 
Liver Size Tender Consistency Pulsation 
 
CNS 
INVESTIGATION 
Hb  % TLC /CM.3 DLC P L M E Sugar/AIB 
BI.Sugar   BI.Urea  S. Cholestral Urine R/M 
S. Creatinine 
 
TREATMENT GIVEN 
Thrombolytic(SK)    Y/N  Dose: 
Anti Ischeamic   Nitrates/B Blocker/CBB 
Antiplatelet    Aspirin/Clopidogrel 
Anticoagulants    LMWH/Heparin  Dose: 
ACE    Dose 
STATINS    Dose 
 
      ECG FINDINGS 
 On 
Admission 
24 
Hrs. 
48 
Hrs. 
72 
Hrs. 
5th Day 7th Day  9th 
Day 
Rate        
Rhythm        
P Wave        
PR Interval        
Width        
Axis        
Q Wave        
Q  Wave        
R Wave        
S Wave        
QT        
QTc Interval        
R/Q ratio in Lead-II        
Maximum QRS 
duration 
       
 
 
ECHOCARDIOGRAPHY 
 
LVEF 
 
      Hypokinesia/ Akinesia/ Normal 
 
Day 1 2 3 4 5 6 7 8 9 10 
Arrhythmias           
LVF           
Echo.           
Other 
Events 
          
 
 
 
Signature of Co-guide                                           
 
Signature of Candidate 
 
GENERAL EXAMINATION 
 
Built:   Thin/Normal/Obese Wt.(Kg):             Ht.(Cm.)   BMI 
 
Pulse R Ry V Ch Syn. Vessel 
Wall 
Peripheral 
pulse  
RFD 
 
 
JVP Ht.(Cm.) A X C V y Others 
 
 
B.P.             Temp.                   Pallor               Cyanosis 
 
Lcterus        Oedema                Xanthoma/Xanthelasma 
 
SYSTEMIC EXAMINATION 
CVS     Inspection: 
 
                 Shape                     Apex Beat 
                  Other Pulsation 
 
             Palpation: 
         
                     Apex beat:                            Thrill:                LPH 
                     Epigastric Pulsation              Palpable P 
 
Auscultation: 
 
 S1 S2 S3 S4         Murmur   Other Sounds 
Mitral     Systolic   
Tricuspid        
Pulmonary        
Aortic        
 
RESP SYSTEM.  Basal Creps 
 
ABDOMEN 
 
Liver Size Tender Consistency Pulsation 
 
